A Study of Olanzapine in Patients With Schizophrenia
Clinical trial NCT00970281 · COMPLETED
Trial details
- NCT number
- NCT00970281
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2011-04-01
- Enrollment
- 91
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.